When examining PCP managed patients, there was no difference in CKD documentation, ACEI/ARB use, urinary albumin quantification, absence of ACEI/ARB and urinary albumin quantification, or Hgb monitoring following the use of eGFR reporting (Figure 3 and Figure 4). This evidence concerns the gene ALB and chronic kidney disease.